Last reviewed · How we verify
NCT03936530
Infrapyloric and Greater Curvature Lymph Node Metastasis in Colon Cancer
trial in Colorectal Neoplasm in 432 participants. Participants enrolled and being followed up; not accepting new ones.
1 August 2023
Quick facts
| Lead sponsor | Shanghai Minimally Invasive Surgery Center |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 432 |
| Start date | 20 October 2019 |
| Primary completion | 1 August 2023 |
| Estimated completion | 1 August 2026 |
| Sites | 1 location across China |
Conditions studied
- Colorectal Neoplasm — all drugs for Colorectal Neoplasm →
Sponsor
Shanghai Minimally Invasive Surgery Center — full company profile →
Who can join
Adults 18 to 75, any sex, with Colorectal Neoplasm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The infrapyloric (No.206) and greater curvature (No.204) lymph node metastasis in adenocarcinoma located at hepatic flexure and right half of transverse colon has not been well discribed and analysed. The aim of this study is to assess the rate of this lymph node metastasis and to reveal its prognostic value for colon cancer located at hepatic flexure and right half of transverse colon. Meanwhile, we can evaluate the safety and feasibility of this extented lymphadenectomy in right hemi-colectomy.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Infrapyloric (No. 206) and greater curvature (No. 204) lymph node metastasis in adenocarcinoma located in the right half of the transverse colon (InCLART Study): protocol for a multicentre prospective observational study.
Yalikun A, Cai Z, Hong HJ, Dai K, et al · · 2023 · cited 2× · PMID 36810166 · DOI 10.1136/bmjopen-2022-066981 -
Analysis of 20 patients with laparoscopic extended right colectomy.
Zheng HD, Xu JH, Liu YR, Sun YF. · · 2022 · cited 2× · PMID 35097078 · DOI 10.12998/wjcc.v10.i2.528
Verify or expand the search:
- PubMed search for NCT03936530
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Colorectal Neoplasm
Currently open trials in the same condition.
- NCT05953662 — Safety and Efficacy of Reduced-port Laparoscopic Surgery for Patients Of Colon and Upper Rectal Cancer · NA · active not recruiting
- NCT05419011 — Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome · Phase 2 · active not recruiting
- NCT04185779 — COLO-COHORT (Colorectal Cancer Cohort) Study · recruiting
- NCT02758951 — Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases · Phase 2, PHASE3 · active not recruiting
- NCT03141437 — Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer · NA · active not recruiting
Other Shanghai Minimally Invasive Surgery Center trials
Trials by the same sponsor.
- NCT07076979 — Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer：MetB · recruiting
- NCT07068529 — Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Colorectal Cancer：M · recruiting
- NCT06746298 — A Prospective Study of Expression Profiling-based Assessment of the Efficacy of Neoadjuvant Therapy for Rectal Cancer · not yet recruiting
- NCT04620473 — Anlotinib Hydrochloride Combined With Capeox in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer · Phase 2 · withdrawn
- NCT05495048 — Transvaginal NOSES Versus Conventional Laparoscopic Surgery for Right Hemicolectomy · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03936530 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai Minimally Invasive Surgery Center
- Last refreshed: 7 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03936530.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing